metaPreg - Caftor during pregnancy

Caftor updated on 02-10-2026

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
1 non statistically significant endpoints reported in only one study
Growth parameters and prematurity
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Preterm (< 37 weeks)	0.90 [0.59, 1.36]	32%	4 studies	238	299	not evaluable	ROB	-
Small for gestational age (weight)	0.38 [0.19, 0.76]	-	1 study	81	147	not evaluable	ROB	4.70 [.; 1.97]
4 non statistically significant endpoints reported in only one study
Maternal consequences
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Caesarean	0.89 [0.55, 1.45]	0%	2 studies	149	103	not evaluable	ROB	-
Gestational diabetes	2.94 [1.98, 4.37]	0%	2 studies	154	172	not evaluable	ROB	5.33 [3.38; .]
Assisted deliveries (forceps, vacuum, ...)	-	-	0 study					-
1 non statistically significant endpoints reported in only one study
Neonatal disorders
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
3 non statistically significant endpoints reported in only one study
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
3 non statistically significant endpoints reported in only one study